Eli Lilly Surges with a 45% Revenue Jump to $12.7 Billion in Q1, Fueled by Mounjaro and Zepbound Success
Eli Lilly reports a 45% revenue surge to $12.73 billion in Q1 2025, driven by Mounjaro and Zepbound. Net income rose by 23% to $2.76 billion, with EPS at $3.06. CEO highlights forg...